Limits...
Selective laser sintering fabrication of nano-hydroxyapatite/poly-ε-caprolactone scaffolds for bone tissue engineering applications.

Xia Y, Zhou P, Cheng X, Xie Y, Liang C, Li C, Xu S - Int J Nanomedicine (2013)

Bottom Line: The in vivo results showed that both nano-HA/PCL composite scaffolds and PCL scaffolds exhibited good biocompatibility.However, the nano-HA/PCL scaffolds enhanced the efficiency of new bone formation more than PCL scaffolds and fulfilled all the basic requirements of bone tissue engineering scaffolds.Thus, they show large potential for use in orthopedic and reconstructive surgery.

View Article: PubMed Central - PubMed

Affiliation: Department of Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.

ABSTRACT
The regeneration of functional tissue in osseous defects is a formidable challenge in orthopedic surgery. In the present study, a novel biomimetic composite scaffold, here called nano-hydroxyapatite (HA)/poly-ε-caprolactone (PCL) was fabricated using a selective laser sintering technique. The macrostructure, morphology, and mechanical strength of the scaffolds were characterized. Scanning electronic microscopy (SEM) showed that the nano-HA/PCL scaffolds exhibited predesigned, well-ordered macropores and interconnected micropores. The scaffolds have a range of porosity from 78.54% to 70.31%, and a corresponding compressive strength of 1.38 MPa to 3.17 MPa. Human bone marrow stromal cells were seeded onto the nano-HA/PCL or PCL scaffolds and cultured for 28 days in vitro. As indicated by the level of cell attachment and proliferation, the nano-HA/PCL showed excellent biocompatibility, comparable to that of PCL scaffolds. The hydrophilicity, mineralization, alkaline phosphatase activity, and Alizarin Red S staining indicated that the nano-HA/PCL scaffolds are more bioactive than the PCL scaffolds in vitro. Measurements of recombinant human bone morphogenetic protein-2 (rhBMP-2) release kinetics showed that after nano-HA was added, the material increased the rate of rhBMP-2 release. To investigate the in vivo biocompatibility and osteogenesis of the composite scaffolds, both nano-HA/PCL scaffolds and PCL scaffolds were implanted in rabbit femur defects for 3, 6, and 9 weeks. The wounds were studied radiographically and histologically. The in vivo results showed that both nano-HA/PCL composite scaffolds and PCL scaffolds exhibited good biocompatibility. However, the nano-HA/PCL scaffolds enhanced the efficiency of new bone formation more than PCL scaffolds and fulfilled all the basic requirements of bone tissue engineering scaffolds. Thus, they show large potential for use in orthopedic and reconstructive surgery.

Show MeSH

Related in: MedlinePlus

Alkaline phosphatase staining of human bone marrow stromal cells cultured on pure PCL and PCL with 5 wt%, 10 wt%, and 15 wt% nano-HA scaffolds at 1 and 2 weeks in common medium.Abbreviations: HA, hydroxyapatite; PCL, poly-ε-caprolactone.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3818022&req=5

f8-ijn-8-4197: Alkaline phosphatase staining of human bone marrow stromal cells cultured on pure PCL and PCL with 5 wt%, 10 wt%, and 15 wt% nano-HA scaffolds at 1 and 2 weeks in common medium.Abbreviations: HA, hydroxyapatite; PCL, poly-ε-caprolactone.

Mentions: The differentiation of hMSCs into osteoblasts was demonstrated by the positive staining of ALP and Alizarin Red S staining (Figures 8 and 9).


Selective laser sintering fabrication of nano-hydroxyapatite/poly-ε-caprolactone scaffolds for bone tissue engineering applications.

Xia Y, Zhou P, Cheng X, Xie Y, Liang C, Li C, Xu S - Int J Nanomedicine (2013)

Alkaline phosphatase staining of human bone marrow stromal cells cultured on pure PCL and PCL with 5 wt%, 10 wt%, and 15 wt% nano-HA scaffolds at 1 and 2 weeks in common medium.Abbreviations: HA, hydroxyapatite; PCL, poly-ε-caprolactone.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3818022&req=5

f8-ijn-8-4197: Alkaline phosphatase staining of human bone marrow stromal cells cultured on pure PCL and PCL with 5 wt%, 10 wt%, and 15 wt% nano-HA scaffolds at 1 and 2 weeks in common medium.Abbreviations: HA, hydroxyapatite; PCL, poly-ε-caprolactone.
Mentions: The differentiation of hMSCs into osteoblasts was demonstrated by the positive staining of ALP and Alizarin Red S staining (Figures 8 and 9).

Bottom Line: The in vivo results showed that both nano-HA/PCL composite scaffolds and PCL scaffolds exhibited good biocompatibility.However, the nano-HA/PCL scaffolds enhanced the efficiency of new bone formation more than PCL scaffolds and fulfilled all the basic requirements of bone tissue engineering scaffolds.Thus, they show large potential for use in orthopedic and reconstructive surgery.

View Article: PubMed Central - PubMed

Affiliation: Department of Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.

ABSTRACT
The regeneration of functional tissue in osseous defects is a formidable challenge in orthopedic surgery. In the present study, a novel biomimetic composite scaffold, here called nano-hydroxyapatite (HA)/poly-ε-caprolactone (PCL) was fabricated using a selective laser sintering technique. The macrostructure, morphology, and mechanical strength of the scaffolds were characterized. Scanning electronic microscopy (SEM) showed that the nano-HA/PCL scaffolds exhibited predesigned, well-ordered macropores and interconnected micropores. The scaffolds have a range of porosity from 78.54% to 70.31%, and a corresponding compressive strength of 1.38 MPa to 3.17 MPa. Human bone marrow stromal cells were seeded onto the nano-HA/PCL or PCL scaffolds and cultured for 28 days in vitro. As indicated by the level of cell attachment and proliferation, the nano-HA/PCL showed excellent biocompatibility, comparable to that of PCL scaffolds. The hydrophilicity, mineralization, alkaline phosphatase activity, and Alizarin Red S staining indicated that the nano-HA/PCL scaffolds are more bioactive than the PCL scaffolds in vitro. Measurements of recombinant human bone morphogenetic protein-2 (rhBMP-2) release kinetics showed that after nano-HA was added, the material increased the rate of rhBMP-2 release. To investigate the in vivo biocompatibility and osteogenesis of the composite scaffolds, both nano-HA/PCL scaffolds and PCL scaffolds were implanted in rabbit femur defects for 3, 6, and 9 weeks. The wounds were studied radiographically and histologically. The in vivo results showed that both nano-HA/PCL composite scaffolds and PCL scaffolds exhibited good biocompatibility. However, the nano-HA/PCL scaffolds enhanced the efficiency of new bone formation more than PCL scaffolds and fulfilled all the basic requirements of bone tissue engineering scaffolds. Thus, they show large potential for use in orthopedic and reconstructive surgery.

Show MeSH
Related in: MedlinePlus